scholarly article | Q13442814 |
P50 | author | Michael Falster | Q42844902 |
Andrea L. Schaffer | Q47599517 | ||
P2093 | author name string | Andrew Wilson | |
David Brieger | |||
Arthur Nasis | |||
Sallie Pearson | |||
Louisa R Jorm | |||
Kira Leeb | |||
Melanie Hay | |||
P2860 | cites work | Oral anticoagulants versus antiplatelet therapy for preventing stroke in patients with non-valvular atrial fibrillation and no history of stroke or transient ischemic attacks | Q24244298 |
Clinical and Economic Implications of AF Related Stroke | Q28077788 | ||
Dabigatran versus warfarin in patients with atrial fibrillation | Q28256895 | ||
Epidemiology of atrial fibrillation: European perspective | Q28315439 | ||
Atrial fibrillation as an independent risk factor for stroke: the Framingham Study | Q29614200 | ||
Rivaroxaban versus warfarin in nonvalvular atrial fibrillation | Q29614696 | ||
The Australian Pharmaceutical Benefits Scheme data collection: a practical guide for researchers | Q31015134 | ||
Refining clinical risk stratification for predicting stroke and thromboembolism in atrial fibrillation using a novel risk factor-based approach: the euro heart survey on atrial fibrillation | Q35003773 | ||
50 year trends in atrial fibrillation prevalence, incidence, risk factors, and mortality in the Framingham Heart Study: a cohort study | Q36005690 | ||
Effect of Adherence to Oral Anticoagulants on Risk of Stroke and Major Bleeding Among Patients With Atrial Fibrillation | Q36714127 | ||
Early real-world evidence of persistence on oral anticoagulants for stroke prevention in non-valvular atrial fibrillation: a cohort study in UK primary care | Q37312543 | ||
Underuse of oral anticoagulants in atrial fibrillation: a systematic review | Q37770666 | ||
Primary non-adherence in general practice: a Danish register study | Q38206382 | ||
Suboptimal Use of Oral Anticoagulants in Atrial Fibrillation: Has the Introduction of Direct Oral Anticoagulants Improved Prescribing Practices? | Q38728028 | ||
Early non-persistence with dabigatran and rivaroxaban in patients with atrial fibrillation | Q38912202 | ||
Estimating the current and future prevalence of atrial fibrillation in the Australian adult population. | Q39058682 | ||
Aspirin Instead of Oral Anticoagulant Prescription in Atrial Fibrillation Patients at Risk for Stroke | Q39658587 | ||
Oral anticoagulants and intracranial hemorrhage. Facts and hypotheses. | Q40458214 | ||
Risk of bleeding with single, dual, or triple therapy with warfarin, aspirin, and clopidogrel in patients with atrial fibrillation | Q42908804 | ||
Temporal trends in medication use and outcomes in atrial fibrillation. | Q43988519 | ||
Outcomes for people with atrial fibrillation in an Australian national audit of stroke care. | Q45802093 | ||
Atrial fibrillation pharmacotherapy after hospital discharge between 1995 and 2004: a shift towards beta-blockers | Q46765460 | ||
Patterns of long-term use of non-vitamin K antagonist oral anticoagulants for non-valvular atrial fibrillation: Quebec observational study. | Q48233579 | ||
The impact of non-vitamin K antagonist oral anticoagulants (NOACs) on anticoagulation therapy in rural Australia. | Q50103243 | ||
Medium- to long-term persistence with non-vitamin-K oral anticoagulants in patients with atrial fibrillation: Australian experience. | Q53345937 | ||
Provider Specialty, Anticoagulation Prescription Patterns, and Stroke Risk in Atrial Fibrillation. | Q54982283 | ||
Risks and benefits of direct oral anticoagulants versus warfarin in a real world setting: cohort study in primary care. | Q55518927 | ||
Stroke prevention in atrial fibrillation | Q56607937 | ||
Rapid and substantial increases in anticoagulant use and expenditure in Australia following the introduction of new types of oral anticoagulants | Q60046275 | ||
National Heart Foundation of Australia and the Cardiac Society of Australia and New Zealand: Australian Clinical Guidelines for the Diagnosis and Management of Atrial Fibrillation 2018 | Q90752977 | ||
Evaluating utilization patterns of oral anticoagulants in routine care | Q91640443 | ||
Management of Patients With Atrial Fibrillation | Q92384979 | ||
Persistence with therapy among patients treated with warfarin for atrial fibrillation | Q95445320 | ||
P433 | issue | 24 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | atrial fibrillation | Q815819 |
P304 | page(s) | e014287 | |
P577 | publication date | 2019-12-04 | |
P1433 | published in | Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease | Q19880670 |
P1476 | title | Evidence-Practice Gaps in Postdischarge Initiation With Oral Anticoagulants in Patients With Atrial Fibrillation | |
P478 | volume | 8 |
Search more.